Skip to main content
. 2021 Jul 22;224(Suppl 6):S647–S659. doi: 10.1093/infdis/jiab335

Table 3.

Two-Way Analysis of Variance Analyses of Angiotensin-Converting Enzyme 2 and Type II Transmembrane Serine Protease Gene and Protein Expression Results

Gene or Protein Maternal SARS-CoV-2 Status  Fetal Sex  Interaction  Bonferroni  Female Neg:Pos  Bonferroni  Male Neg:Pos  Bonferroni Neg Female:Male  Bonferroni Pos Female:Male 
Gene
 ACE2 F(1,64) = 0.003, P = .95  F(1,64) = 3.59, P = .06  F(1,64) = 0.627, P = .43  P > .99  P > .99  P = .46  P > .99 
 TMPRSS2 F(1,64) = 0.889, P = .35  F(1,64) = 3.56, P = .06  F (1,64)  = 10.65, P = .002 P = .63  P = .025 P = .006 P > .99 
Protein by Western blot 
ACE2  F(1,52) = 0.006, P = .94  F(1,52) = 0.0008, P = .98  F(1,52) = 0.89, P = .35  P = .93  P = .89  P = .90  P = .92 
TMPRSS2  F(1,52) = 0.02, P = .90  F(1,52) = 0.21, P = .65  F (1,52)  = 16.57, P = .0002 P =.027 P =.044 P =.014 P = .081 

Two-way analysis of variance followed by Bonferroni post hoc analyses was performed to determine significance. All main and interaction effects for genes and proteins of interest are represented for both fetal males and fetal females in addition to all post hoc analyses performed. Statistically significant values are bolded.  “Neg” and “Pos” designate maternal SARS-CoV-2 status.

Abbreviations: ACE2, angiotensin-converting enzyme 2; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TMPRSS2, type II transmembrane serine protease.